Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity.

Shanker A, Pellom ST Jr, Dudimah DF, Thounaojam MC, de Kluyver RL, Brooks AD, Yagita H, McVicar DW, Murphy WJ, Longo DL, Sayers TJ.

Cancer Res. 2015 Dec 15;75(24):5260-72. doi: 10.1158/0008-5472.CAN-15-0794. Epub 2015 Oct 22.

2.

A 1536-well quantitative high-throughput screen to identify compounds targeting cancer stem cells.

Mathews LA, Keller JM, Goodwin BL, Guha R, Shinn P, Mull R, Thomas CJ, de Kluyver RL, Sayers TJ, Ferrer M.

J Biomol Screen. 2012 Oct;17(9):1231-42. Epub 2012 Aug 27.

PMID:
22927676
3.

Coactivation of AKT and β-catenin in mice rapidly induces formation of lipogenic liver tumors.

Stauffer JK, Scarzello AJ, Andersen JB, De Kluyver RL, Back TC, Weiss JM, Thorgeirsson SS, Wiltrout RH.

Cancer Res. 2011 Apr 1;71(7):2718-27. doi: 10.1158/0008-5472.CAN-10-2705. Epub 2011 Feb 15.

4.

Antigen-specific CD8 T cells can eliminate antigen-bearing keratinocytes with clonogenic potential via an IFN-gamma-dependent mechanism.

De Kluyver RL, Moritz L, Harris CA, Azukizawa H, Frazer IH.

J Invest Dermatol. 2010 Jul;130(7):1841-8. doi: 10.1038/jid.2010.49. Epub 2010 Mar 18.

5.

Breast cancer bone metastases: combination therapy targeting cancer cells and the tumor microenvironment.

de Kluyver RL, Sayers TJ.

Cancer Biol Ther. 2010 Apr 1;9(7):551-3. Epub 2010 Apr 1. No abstract available.

PMID:
20234180
6.
7.

Impaired antigen presentation and effectiveness of combined active/passive immunotherapy for epithelial tumors.

Matsumoto K, Leggatt GR, Zhong J, Liu X, de Kluyver RL, Peters T, Fernando GJ, Liem A, Lambert PF, Frazer IH.

J Natl Cancer Inst. 2004 Nov 3;96(21):1611-9.

PMID:
15523090
8.

Interferon-gamma enhances cytotoxic T lymphocyte recognition of endogenous peptide in keratinocytes without lowering the requirement for surface peptide.

Leggatt GR, Dunn LA, De Kluyver RL, Stewart T, Frazer IH.

Immunol Cell Biol. 2002 Oct;80(5):415-24.

PMID:
12225377
9.

Presentation of the HPV16E7 protein by skin grafts is insufficient to allow graft rejection in an E7-primed animal.

Dunn LA, Evander M, Tindle RW, Bulloch AL, de Kluyver RL, Fernando GJ, Lambert PF, Frazer IH.

Virology. 1997 Aug 18;235(1):94-103.

Supplemental Content

Loading ...
Support Center